| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Careers Employment > Evaluating Job Offers -- Eleven Warning Signs You Must Watch Out For |
|
Advice Pool - Evaluating Job Offers -- Eleven Warning Signs You Must Watch Out For
Moving into a new job always involves some degree of uncertainty. You should do your best to find out all you can about a prospect According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ive employer, starting right from the pre-interview stage. Here are some things to look out for. If one or more of these warning ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in signs are present, you need to be doubly careful about joining that organization. 1. The company is in the midst of mergers and a lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. cquisitions, or there is a major reorganization taking place, staff cutbacks are on the anvil or some other major flux is occurrin here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe g. 2. The company you are considering is not undergoing problems like those described above, but many other companies in that ind d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro stry are. That could be an indication that trouble may spread to your prospective employer sooner or later. 3. The person who wil ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc l be your boss has a bad reputation. This is something you should find out about from your network. 4. Your prospective boss has easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi joined the organization very recently and his or her reputation is generally not known. 5. You asked to meet with and speak to yo nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ur new colleagues and this request was refused. What are they afraid the existing employees will say to a prospective new hire? 6 and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ . This is a non-profit organization that has had funding problems several times before. In such cases, think twice before taking u ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi a position. 7. They told you a story about the company or about your career prospects that sounded too good to be true. When som ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ething sounds that way, it usually is. 8. The company is a small business that is not very profitable and does not seem to have a dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ccess to strong funding sources. It’s very easy for small businesses to go bankrupt if they’re mismanaged to any degree. 9. The p cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin osition you are being offered has high turnover. This is usually a bad sign. 10. The interviewers keep saying that they want you tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen to hit the ground running from day one. This may imply that they don’t have the means to provide enough support for your role. Thi t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s could be a problem particularly if you’re used to working for large organizations that do provide lots of support. 11. The whol ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust interviewing process was done in a big hurry or in a disorganized manner, leaving you in doubt whether they really had a chance t y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products o know you. The presence of a warning sign from the list above does not necessarily mean you have to write off that organization . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de as an employer. It does mean that you must get all additional information you need. Perhaps you could get an opinion from a truste elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip d friend who is familiar with the industry and company. You need to do some serious thinking before you make a decision either way tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Capture Clients' Attention - Sharing Success - and the Death of Prospecting! The Big Uneasy: Clearing the Clouds of Guess
|